Phase 1 Parkinson's Disease (PD) Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1
Relative Bioavailability Study of HNC364 Injectable Suspension
Parkinson's Disease (PD)
Guangzhou Henovcom Bioscience Co. Ltd.30 enrolled1 locationNCT06798519
Recruiting
Phase 1Phase 2
Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)
Parkinson's Disease (PD)
EicOsis Human Health Inc.18 enrolled1 locationNCT07142044